Safety and efficacy of tacrolimus rescue therapy in 55 kidney transplant patients treated with cyclosporine

被引:8
作者
Urbizu, JM [1 ]
Zárraga, S [1 ]
Gómez-Ullate, P [1 ]
Amenábar, JJ [1 ]
Gaínza, FI [1 ]
Lampreabe, I [1 ]
Virto, J [1 ]
Orbe, J [1 ]
机构
[1] Hosp Cruces, Serv Nephrol, Baracaldo, Bizkaia, Spain
关键词
D O I
10.1016/S0041-1345(03)00610-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
To evaluate the efficacy and safety of conversion from cyclosporine to tacrolimus, we analyzed 55 kidney transplant patients who were converted due to cosmetic reasons in 42 patients, acute rejection in 2 patients, and other causes in 11 patients. At the doses and levels used, the development of diabetes mellitus was minimized. Disappearance of cosmetic side-effects and improvement of cardiovascular risk factors, together with conservation of renal function, encourage us to use tacrolimus as an efficacious and safe immunosuppressive therapy.
引用
收藏
页码:1704 / 1705
页数:2
相关论文
共 9 条
[1]
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: Results at 2 years [J].
Ahsan, N ;
Johnson, C ;
Gonwa, T ;
Halloran, P ;
Stegall, M ;
Hardy, M ;
Metzger, R ;
Shield, C ;
Rocher, L ;
Scandling, J ;
Sorensen, J ;
Mulloy, L ;
Light, J ;
Corwin, C ;
Danovitch, G ;
Wachs, M ;
VanVeldhuisen, P ;
Salm, K ;
Tolzman, D ;
Fitzsimmons, WE .
TRANSPLANTATION, 2001, 72 (02) :245-250
[2]
Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients [J].
Boots, JMM ;
van Duijnhoven, EM ;
Christiaans, MHL ;
Nieman, FHM ;
van Suylen, RJ ;
van Hooff, JP .
TRANSPLANT INTERNATIONAL, 2001, 14 (06) :370-383
[3]
Indications, results, and complications of tacrolimus conversion in pediatric renal transplantation [J].
Flynn, JT ;
Bunchman, TE ;
Sherbotie, JR .
PEDIATRIC TRANSPLANTATION, 2001, 5 (06) :439-446
[4]
Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus [J].
Hernández, G ;
Arriba, L ;
Lucas, M ;
de Andrés, A .
JOURNAL OF PERIODONTOLOGY, 2000, 71 (10) :1630-1636
[5]
Kohnle M, 2000, Transpl Int, V13 Suppl 1, pS345, DOI 10.1007/s001470050358
[6]
Koomans HA, 2001, TRANSPLANTATION, V72, pS9
[8]
Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression [J].
Shield, CF ;
McGrath, MM ;
Goss, TF .
TRANSPLANTATION, 1997, 64 (12) :1738-1743
[9]
A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: Evidence for improved allograft survival at five years [J].
Vicenti, F ;
Jensik, SC ;
Filo, RS ;
Miller, J ;
Pirsch, J .
TRANSPLANTATION, 2002, 73 (05) :775-782